News

December 11, 2025

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis

November 20, 2025

Strathclyde Spinout Dxcover wins Deal of the Year (sub £10 Million) at the Insider Scotland Dealmakers Awards 2025

October 29, 2025

CamGene Therapeutics Announces Seed Round to Advance RNA Therapeutics for Hearing Loss

October 22, 2025

Deep-tech spinout Chemify raises $50 million

August 28, 2025

Eos leads £4.5M seed round into Ensilitech

June 30, 2025

Laverock raises £20M+ in seed financing

All News

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis

December 11, 2025

Read more

Strathclyde Spinout Dxcover wins Deal of the Year (sub £10 Million) at the Insider Scotland Dealmakers Awards 2025

November 20, 2025

Read more

CamGene Therapeutics Announces Seed Round to Advance RNA Therapeutics for Hearing Loss

October 29, 2025

Read more

Deep-tech spinout Chemify raises $50 million

October 22, 2025

Read more

Eos leads £4.5M seed round into Ensilitech

August 28, 2025

Read more

Laverock raises £20M+ in seed financing

June 30, 2025

Read more

Dxcover Launches US Operations

June 24, 2025

Read more

Chemify launch £12M Glasgow AI-facility

June 20, 2025

Read more

Naturbeads wins Best EIS Investee Company at the EISA Awards 2025

June 20, 2025

Read more

Bioliberty Launches Lifehub Clinic with Soft-Robotic Lifeglov

May 13, 2025

Read more

Wobble announces US Chair, Dr Dietrich Stephan

May 6, 2025

Read more

Portfolio company Dxcover presents evidence from brain cancer study

April 30, 2025

Read more

Latest news

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis
11 December 2025
Strathclyde Spinout Dxcover wins Deal of the Year (sub £10 Million) at the Insider Scotland Dealmakers Awards 2025
20 November 2025

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.